Trilaciclib
Product Specifications
CAS Number
1374743-00-6
Target
Cell Cycle Arrest|||CDK
Related Pathways
Cell Cycle/Checkpoint
Purity
0.9962
Bioactivity
Trilaciclib is a short-acting, orally effective CDK4/6 inhibitor with IC?? values of 1 nM and 4 nM respectively. It transiently and reversibly induces G1 cell cycle arrest, mitigates chemotherapy-induced myelosuppression, and enhances antitumour immunity, making it applicable across multiple cancers.
Smiles
CN1CCN(CC1)c1ccc(Nc2ncc3cc4C(=O)NCC5(CCCCC5)n4c3n2)nc1
Molecular Formula
C24H30N8O
Molecular Weight
446.55
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
G8957-15J 100 µg
Granzyme B (C11, Cathespin G Like 1, CCP1, CGL1, CSPB, CTLA1, CTSGL1, Cytotoxic serine protease B, Cytotoxic T Lymphocyte Cytotoxic T lymphocyte proteinase 2, EC 3.4.21.79, Fragmentin 2, Granzyme 2, GRB, GZMB, HLP, Human lymphocyte protein, Lymphocyte protease, Protease Serine B, SECT) discontinued
Ask
View Details 
MBS6490656-01 0.1 mL
Nuclear Receptor LXR beta, NT (NR1H2, Liver X Receptor beta, LX Receptor beta, LXR beta, LXRB, LXR-b, NER1, NERI, NER-I, Nuclear Orphan Receptor LXR beta, Nuclear Receptor NER, Nuclear Receptor Subfamily 1 Group H Member 2, Oxysterols Receptor LXR beta, R
Ask
View Details 
MBS6490656-02 5x 0.1 mL
Nuclear Receptor LXR beta, NT (NR1H2, Liver X Receptor beta, LX Receptor beta, LXR beta, LXRB, LXR-b, NER1, NERI, NER-I, Nuclear Orphan Receptor LXR beta, Nuclear Receptor NER, Nuclear Receptor Subfamily 1 Group H Member 2, Oxysterols Receptor LXR beta, R
Ask
View Details